The Role and Significance of Biomarker for Plasma G-CSF in Patients with Primary Lung Cancer |
Song, Jung Sub
(Department of Internal Medicine, Wonkwang University College of Medicine)
Kim, So Young (Department of Internal Medicine, Wonkwang University College of Medicine) Jo, Hyang Jeong (Department of Pathology, Wonkwang University College of Medicine) Lee, Kang Kyoo (Department of Therapeutic Radiology & Oncology, Wonkwang University College of Medicine) Shin, Jeong Hyun (Department of Internal Medicine, Wonkwang University College of Medicine) Shin, Seong Nam (Department of Internal Medicine, Wonkwang University College of Medicine) Kim, Dong (Department of Internal Medicine, Wonkwang University College of Medicine) Park, Seong Hoon (Department of Radiology, Wonkwang University College of Medicine) Lee, Young Jin (Department of Clinical Pathology, Wonkwang University College of Medicine) Ko, Chang Bo (Good Cell Life, Inc.) Lee, Mi Kung (Department of Thoracic Surgery, Wonkwang University College of Medicine) Choi, Soon Ho (Department of Thoracic Surgery, Wonkwang University College of Medicine) Jeong, Jong Hoon (Department of Internal Medicine, Wonkwang University College of Medicine) Park, Jung Hyun (Department of Internal Medicine, Wonkwang University College of Medicine) Kim, Hui Jung (Department of Internal Medicine, Wonkwang University College of Medicine) Kim, Hak Ryul (Department of Internal Medicine, Wonkwang University College of Medicine) Jeong, Eun Taik (Department of Internal Medicine, Wonkwang University College of Medicine) Yang, Sei Hoon (Department of Internal Medicine, Wonkwang University College of Medicine) |
1 | Albain KS, Crowley JJ, Livingston RB. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. Chest 1991;99: 1425-32 DOI ScienceOn |
2 | Muller LC, Gasser R, Huber H, Klingler A, Salzer GM. Neuron-specific enolase (NSE) in small-cell lung cancer: longitudinal tumors marker evaluation. Lung Cancer 1992;8:29-36 DOI ScienceOn |
3 | Miyagawa K, Chiba S, Shibuya K, Piao YF, Matsuki S, Yokota J, et al. Frequent expression of receptors for granulocyte-macrophage colony-stimulating factor on human nonhematopoietic tumor cell lines. J Cell Physiol 1990;143:483-7 DOI PUBMED |
4 | Body JJ, Sculier JP, Raymakers N, Paesmans M, Ravez P, Libert P, et al. Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer. Cancer 1990;65:1552-6 DOI ScienceOn |
5 | Mroczko B, Szmitkowski M, Okulczyk B. Granulocytecolony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients. Clin Chem Lab Med 2002;40:351-5 DOI ScienceOn |
6 | Mroczko B, Szmitkowski M. Hematopoietic cytokines as tumor markers. Clin Chem Lab Med 2004;42:1347-54 DOI ScienceOn |
7 | Asano S, Urabe A, Okabe T, Sato N, Kondo Y. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood 1977;49:845-52 PUBMED |
8 | Sculier JP, Body JJ, Jacobowitz D, Fruhling J. Value of CEA determination in biological fluids and tissues. Eur J Cancer Clin Oncol 1987;23:1091-3 DOI ScienceOn |
9 | Yee LD, Liu L. The constitutive production of colony stimulating factor 1 by invasive human breast cancer cells. Anticancer Res 2000;20:4379-83 PUBMED |
10 | Turner AM, Zsebo KM, Martin F, Jacobsen FW, Bennett LG, Broudy VC. Nonhematopoietic tumor cell lines express stem cell factor and display c-kit receptors. Blood 1992;80:374-81 PUBMED |
11 | Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108 DOI ScienceOn |
12 | Tani K, Ozawa K, Ogura H, Shimane M, Shirafuji N, Tsuruta T, et al. Expression of granulocyte and granulocyte macrophage colony-stimulating factors by human non-hematopoietic tumor cells. Growth Factors 1990;3:325-31 DOI ScienceOn |
13 | Wieskopf B, Demangeat C, Purohit A, Stenger R, Gries P, Kreisman H, et al. Cyfra 21-1 as a biologic marker of non-small cell lung cancer: evaluation of sensitivity, specificity, and prognostic role. Chest 1995;108:163-9 DOI ScienceOn |
14 | Bonomi P, Gale M, Rowland K, Taylor SG 4th, Purl S, Reddy S, et al. Pre-treatment prognostic factors in stage III non-small cell lung cancer patients receiving combined modality treatment. Int J Radiat Oncol Biol Phys 1991;20:247-52 DOI PUBMED ScienceOn |
15 | Buccheri G, Ferrigno D. Usefulness of tissue polypeptide antigen in staging, monitoring, and prognosis of lung cancer. Chest 1988;93:565-70 DOI ScienceOn |
16 | Kobashi Y, Okimoto N, sakamoto K. Squamous cell carcinoma of the lung producing granulocyte colonystimulating factor and resembling a malignant pleural mesothelioma. Intern Med 2004;43:111-6 DOI ScienceOn |
17 | Watari K, Asano S, Shirafuji N, Kodo H, Ozawa K, Takaku F, et al. Serum granulocyte colony-stimulating factor levels in healthy volunteers and patients with various disorders as estimated by enzyme immunoassay. Blood 1989;73:117-22 PUBMED |
18 | Usami N, Uchiyama M, Kawaguchi K, Yasuda A, Ito S, Yokoi K. Granulocyte colony-stimulating factor-producing malignant pleural mesothelioma. J Thorac Oncol 2007;2:257-8 DOI ScienceOn |
19 | Tsuruta N, Yatsunami J, Takayama K, Nakanishi Y, Ichinose Y, Hara N. Granulocyte-macrophage-colony stimulating factor stimulates tumor invasiveness in squamous cell lung carcinoma. Cancer 1998;82:2173-83 DOI ScienceOn |
20 | Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-33S PUBMED |
21 | McDermott RS, Deneux L, Mosseri V, Védrenne J, Clough K, Fourquet A, et al. Circulating macrophage colony stimulating factor as a marker of tumor progression. Eur Cytokine Netw 2002;13:121-7 PUBMED |
22 | Buccheri G, Ferrigno D. Lung tumor markers of cytokeratin origin: an overview. Lung Cancer 2001;34 Suppl 2:S65-9 |
23 | Karnak D, Ulubay G, Kayacan O, Beder S, Ibis E, Oflaz G. Evaluation of Cyfra 21-1: a potential tumor marker for non-small cell lung carcinomas. Lung 2001;179: 57-65 DOI ScienceOn |
24 | Mino N, Iio A, Hamamoto K. Availability of tumor-antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 1988;62:730-4 DOI ScienceOn |
25 | Hasegawa S, Suda T, Negi K, Hattori Y. Lung large cell carcinoma producing granulocyte-colony stimulating factor. Ann Thorac Surg 2007;83:308-10 DOI ScienceOn |
26 | Cooper DL. Tumor markers. In: Goldman L, Bennett JC, editors. Cecil textbook of medicine. 21st ed. Philadelphia: W.B. Saunders company; 2000. p. 1039-42 |
27 | Akoun GM, Scarna HM, Milleron BJ, Bénichou MP, Herman DP. Serum neuron-specific enolase: a marker for disease extent and response to therapy for smallcell lung cancer. Chest 1985;87:39-43 DOI ScienceOn |
28 | Mroczko B, Groblewska M, Wereszczynska-Siemiatkowska U, Okulczyk B, Kedra B, Laszewicz W, et al. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis. Clin Chim Acta 2007; 380:208-12 DOI ScienceOn |